The global Non-alcoholic Steatohepatitis (NASH) Biomarkers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Non-alcoholic Steatohepatitis (NASH) Biomarkers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Non-alcoholic Steatohepatitis (NASH) Biomarkers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers include Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories and Gilead Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Non-alcoholic Steatohepatitis (NASH) Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-alcoholic Steatohepatitis (NASH) Biomarkers.

Report Scope

The Non-alcoholic Steatohepatitis (NASH) Biomarkers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-alcoholic Steatohepatitis (NASH) Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-alcoholic Steatohepatitis (NASH) Biomarkers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Report

Report Metric	Details
Report Name	Non-alcoholic Steatohepatitis (NASH) Biomarkers Market
Segment by Type	Serum Biomarkers Cytokeratin-18 (CK 18) Marker Inflammatory Markers Others
Segment by Application	Hospitals Diagnostic Centers Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories, Gilead Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-alcoholic Steatohepatitis (NASH) Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market report?

Ans: The main players in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market are Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories, Gilead Sciences

What are the Application segmentation covered in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market report?

Ans: The Applications covered in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market report are Hospitals, Diagnostic Centers, Others

What are the Type segmentation covered in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market report?

Ans: The Types covered in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market report are Serum Biomarkers, Cytokeratin-18 (CK 18) Marker, Inflammatory Markers, Others

1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview

1.1 Product Overview and Scope of Non-alcoholic Steatohepatitis (NASH) Biomarkers

1.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Type

1.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Type (2024-2030)

1.2.2 Serum Biomarkers

1.2.3 Cytokeratin-18 (CK 18) Marker

1.2.4 Inflammatory Markers

1.2.5 Others

1.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Application

1.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Diagnostic Centers

1.3.4 Others

1.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size Estimates and Forecasts

1.4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue 2019-2030

1.4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales 2019-2030

1.4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competition by Manufacturers

2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Manufacturers (2019-2024)

2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price by Manufacturers (2019-2024)

2.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Product Type & Application

2.7 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Situation and Trends

2.7.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players Market Share by Revenue

2.7.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Retrospective Market Scenario by Region

3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region: 2019-2030

3.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region: 2019-2024

3.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region: 2025-2030

3.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2019-2030

3.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2019-2024

3.3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2025-2030

3.4 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country

3.4.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2019-2030)

3.4.3 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country

3.5.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2019-2030)

3.5.3 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country

3.6.1 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2019-2030)

3.6.3 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country

3.7.1 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2019-2030)

3.7.3 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country

3.8.1 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2019-2030)

3.8.3 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2019-2030)

4.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2019-2024)

4.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2025-2030)

4.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2019-2030)

4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Type (2019-2030)

4.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Type (2019-2024)

4.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Type (2025-2030)

4.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2019-2030)

4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Type (2019-2030)

5 Segment by Application

5.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2019-2030)

5.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2019-2024)

5.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2025-2030)

5.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2019-2030)

5.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Application (2019-2030)

5.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Application (2019-2024)

5.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Application (2025-2030)

5.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2019-2030)

5.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Biopredictive

6.1.1 Biopredictive Corporation Information

6.1.2 Biopredictive Description and Business Overview

6.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.1.5 Biopredictive Recent Developments/Updates

6.2 Quest Diagnostics

6.2.1 Quest Diagnostics Corporation Information

6.2.2 Quest Diagnostics Description and Business Overview

6.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.2.5 Quest Diagnostics Recent Developments/Updates

6.3 Exalenz Bioscience

6.3.1 Exalenz Bioscience Corporation Information

6.3.2 Exalenz Bioscience Description and Business Overview

6.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.3.5 Exalenz Bioscience Recent Developments/Updates

6.4 GENFIT

6.4.1 GENFIT Corporation Information

6.4.2 GENFIT Description and Business Overview

6.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.4.5 GENFIT Recent Developments/Updates

6.5 Siemens Healthineers

6.5.1 Siemens Healthineers Corporation Information

6.5.2 Siemens Healthineers Description and Business Overview

6.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.5.5 Siemens Healthineers Recent Developments/Updates

6.6 ONE WAY LIVER

6.6.1 ONE WAY LIVER Corporation Information

6.6.2 ONE WAY LIVER Description and Business Overview

6.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2019-2024)

6.6.4 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.6.5 ONE WAY LIVER Recent Developments/Updates

6.7 Prometheus Laboratories

6.6.1 Prometheus Laboratories Corporation Information

6.6.2 Prometheus Laboratories Description and Business Overview

6.6.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.7.5 Prometheus Laboratories Recent Developments/Updates

6.8 Gilead Sciences

6.8.1 Gilead Sciences Corporation Information

6.8.2 Gilead Sciences Description and Business Overview

6.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.8.5 Gilead Sciences Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Chain Analysis

7.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Mode & Process

7.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Marketing

7.4.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Channels

7.4.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors

7.5 Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers

8 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics

8.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Trends

8.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers

8.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges

8.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Prometheus Laboratories

Gilead Sciences

List of Tables

Table 1. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Situation by Manufacturers in 2023

Table 4. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Product Type & Application

Table 12. Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2019-2024) & (K Units)

Table 18. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2019-2024)

Table 19. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2025-2030) & (K Units)

Table 20. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2025-2030)

Table 21. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2019-2024)

Table 23. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2025-2030)

Table 25. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2019-2024) & (K Units)

Table 27. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2025-2030) & (K Units)

Table 28. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2019-2024) & (K Units)

Table 32. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2025-2030) & (K Units)

Table 33. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Type (2019-2024)

Table 51. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Type (2025-2030)

Table 52. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2019-2024)

Table 53. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2025-2030)

Table 54. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2019-2024)

Table 57. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2025-2030)

Table 58. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2019-2024)

Table 59. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2025-2030)

Table 60. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2019-2024)

Table 61. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2025-2030)

Table 62. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2019-2024)

Table 63. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2025-2030)

Table 64. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2019-2024)

Table 67. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2025-2030)

Table 68. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2019-2024)

Table 69. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2025-2030)

Table 70. Biopredictive Corporation Information

Table 71. Biopredictive Description and Business Overview

Table 72. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

Table 74. Biopredictive Recent Developments/Updates

Table 75. Quest Diagnostics Corporation Information

Table 76. Quest Diagnostics Description and Business Overview

Table 77. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

Table 79. Quest Diagnostics Recent Developments/Updates

Table 80. Exalenz Bioscience Corporation Information

Table 81. Exalenz Bioscience Description and Business Overview

Table 82. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

Table 84. Exalenz Bioscience Recent Developments/Updates

Table 85. GENFIT Corporation Information

Table 86. GENFIT Description and Business Overview

Table 87. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

Table 89. GENFIT Recent Developments/Updates

Table 90. Siemens Healthineers Corporation Information

Table 91. Siemens Healthineers Description and Business Overview

Table 92. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

Table 94. Siemens Healthineers Recent Developments/Updates

Table 95. ONE WAY LIVER Corporation Information

Table 96. ONE WAY LIVER Description and Business Overview

Table 97. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

Table 99. ONE WAY LIVER Recent Developments/Updates

Table 100. Prometheus Laboratories Corporation Information

Table 101. Prometheus Laboratories Description and Business Overview

Table 102. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

Table 104. Prometheus Laboratories Recent Developments/Updates

Table 105. Gilead Sciences Corporation Information

Table 106. Gilead Sciences Description and Business Overview

Table 107. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

Table 109. Gilead Sciences Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List

Table 113. Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers List

Table 114. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends

Table 115. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers

Table 116. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges

Table 117. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Non-alcoholic Steatohepatitis (NASH) Biomarkers

Figure 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Type in 2023 & 2030

Figure 4. Serum Biomarkers Product Picture

Figure 5. Cytokeratin-18 (CK 18) Marker Product Picture

Figure 6. Inflammatory Markers Product Picture

Figure 7. Others Product Picture

Figure 8. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Application in 2023 & 2030

Figure 10. Hospitals

Figure 11. Diagnostic Centers

Figure 12. Others

Figure 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size (2019-2030) & (US$ Million)

Figure 15. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (2019-2030) & (K Units)

Figure 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price (US$/Unit) & (2019-2030)

Figure 17. Non-alcoholic Steatohepatitis (NASH) Biomarkers Report Years Considered

Figure 18. Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Manufacturers in 2023

Figure 19. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players: Market Share by Revenue in 2023

Figure 21. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2019-2030)

Figure 24. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2019-2030)

Figure 25. United States Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2019-2030)

Figure 28. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2019-2030)

Figure 29. Germany Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2019-2030)

Figure 36. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2019-2030)

Figure 46. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2019-2030)

Figure 56. Global Revenue Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2019-2030)

Figure 57. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2019-2030)

Figure 59. Global Revenue Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2019-2030)

Figure 60. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2019-2030)

Figure 61. Non-alcoholic Steatohepatitis (NASH) Biomarkers Value Chain

Figure 62. Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26N13078

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3L13782

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26S13718

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16S12875

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions